Mauricio Cambeiro

ORCID: 0000-0001-5959-7380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Endometrial and Cervical Cancer Treatments
  • Sarcoma Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Ovarian cancer diagnosis and treatment
  • Prostate Cancer Treatment and Research
  • Colorectal and Anal Carcinomas
  • Head and Neck Surgical Oncology
  • Prostate Cancer Diagnosis and Treatment
  • Management of metastatic bone disease
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Colorectal Cancer Surgical Treatments
  • Bone Tumor Diagnosis and Treatments
  • Vascular Tumors and Angiosarcomas
  • Lung Cancer Diagnosis and Treatment
  • Radiation Therapy and Dosimetry
  • Radiomics and Machine Learning in Medical Imaging
  • Effects of Radiation Exposure
  • Uterine Myomas and Treatments
  • Glioma Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Ear and Head Tumors
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cervical Cancer and HPV Research

Clinica Universidad de Navarra
2016-2025

Advanced Radiation Therapy (United States)
2023-2024

Gynecologic Oncology Group
2023-2024

NYU Langone Health
2023-2024

Spanish Oncology Genitourinary Group
2023-2024

Stellar Science (United States)
2023-2024

Memorial Sloan Kettering Cancer Center
2023

Universidad de Navarra
2011-2022

Georgetown University Medical Center
2020

Georgetown University
2020

Full-dose postoperative external beam radiation therapy (EBRT)/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine long-term results adjuvant high-dose rate (HDR) brachytherapy ± intermediate-dose this HNC patient population. From 2000 2018, a total 152 diagnosed were treated surgery HDR alone (n = 32) or combined EBRT chemotherapy 120). Patients received 32 40 Gy 8 10 b.i.d. fractions. Combined modality 16...

10.1002/hed.28131 article EN Head & Neck 2025-03-10

Simultaneous chemoradiation is used in unresectable pancreatic cancer for palliation. It not known if the use of adjuvant surgery will benefit this group patients. From November 1991 to September 1998, 47 patients with were treated simultaneous preoperative radiation therapy (45 Gy) and chemotherapy. Chemotherapy followed three different protocols: cisplatin, 5-fluorouracil ± paclitaxel; (protracted infusion); docetaxel gemcitabine. Whipple pancreatoduodenectomy was performed 1 month after...

10.1097/00000421-200302000-00007 article EN American Journal of Clinical Oncology 2003-02-01

This study aimed to test the safety of using perioperative high-dose-rate brachytherapy (PHDRB) in resected head and neck cancer.From 2000 2008, 97 patients received PHDRB after complete macroscopic resection. Group 1 (previously irradiated patients) 32 40 Gray (Gy) 8 10 twice-daily (bid) treatments (R0-R1 resections). 2 (unirradiated 16 24 Gy 4 6 bid resections) followed by external beam irradiation (EBRT) 45 Gy/25 daily fractions ± concomitant chemotherapy.The median follow-up was 4.3...

10.1002/hed.21874 article EN Head & Neck 2012-01-20
Coming Soon ...